Trescal announces the acquisition of RS Calibration, an A2LA-accredited calibration, qualification and validation laboratory dedicated primarily to the life sciences sector.
Founded in 1995 and located in Pleasanton (northeast of San Francisco), RS Calibration employs 41 people and offers on-site and laboratory calibration and validation services in particular to manufacturers in the pharmaceutical, biotech and medical device sectors. The company, which specializes in the requirements of FDA and cGMP environments, posted sales of $5.5 million in 2017.
Its founder and CEO, Ralph Sabiel, will stay on to continue the development of this entity within the Trescal group.
Guillaume Caroit, Trescal Managing Director: " This acquisition is very important for Trescal's development in the US market, as it extends our geographical coverage in California and strengthens our service offering for the life sciences sector, one of the most dynamic in the United States. "
This is the first acquisition since Trescal was taken over by Omers, the main shareholder.
of the Trescal group.
Learn more: www.trescal.com